• Home
  • About Us
  • Contact Us
  • Privacy Policy
  • Special Offers
Business Intelligence Info
  • Business Intelligence
    • BI News and Info
    • Big Data
    • Mobile and Cloud
    • Self-Service BI
  • CRM
    • CRM News and Info
    • InfusionSoft
    • Microsoft Dynamics CRM
    • NetSuite
    • OnContact
    • Salesforce
    • Workbooks
  • Data Mining
    • Pentaho
    • Sisense
    • Tableau
    • TIBCO Spotfire
  • Data Warehousing
    • DWH News and Info
    • IBM DB2
    • Microsoft SQL Server
    • Oracle
    • Teradata
  • Predictive Analytics
    • FICO
    • KNIME
    • Mathematica
    • Matlab
    • Minitab
    • RapidMiner
    • Revolution
    • SAP
    • SAS/SPSS
  • Humor

Tag Archives: vaccines

Vaccines are Coming!

December 11, 2020   Humor

And not just for the coronavirus. We are going to need a whole bunch of novel vaccines to get things back on track.

© KAL – The Economist
 If you liked this, you might also like these related posts:
  1. Coming out of the WC
  2. The Future is Coming
  3. Law and Order?
  4. The New Normal?
  5. The Future?

Let’s block ads! (Why?)

Political Irony

Read More

Alphabet investment arm GV backs SpyBiotech, an Oxford University spinout working on ‘next-generation’ vaccines

April 2, 2017   Big Data
 Alphabet investment arm GV backs SpyBiotech, an Oxford University spinout working on ‘next generation’ vaccines

SpyBiotech, a life sciences spinout from the U.K.’s Oxford University, has raised £4 million ($ 5 million) in seed funding from Oxford Sciences Innovation (OSI) and Alphabet investment arm GV (formerly Google Ventures).

As traditional approaches to developing vaccines are typically time-consuming, and not always effective, SpyBiotech is working on what it calls a “proprietary protein superglue” technology. Called SpyTag/SpyCatcher, it makes it possible to create vaccines “more quickly, cheaply, and effectively,” according to the company.

A clue to the company’s raison d’être comes from its name, which borrows from the species of bacteria known as Streptococcus pyogenes (Spy), which many people may know from common infections such as strep throat. The company split Spy into a peptide (SpyTag) and protein partner (SpyCatcher). But when separated the two have an overwhelming urge to rejoin each other — and this is the basis of the biochemical superglue that SpyBiotech believes is the “missing link” in the development of effective vaccines.

The company will initially focus on infectious diseases, including viral infections, but it plans to develop its technology further and apply it to “a wide variety of conditions,” covering any number of future outbreaks and pandemics. The funding will be used to initiate phase I trials, and the company is already planning another round of funding “in the near future” to work in other areas.

“Researchers in the vaccine field, including us, have struggled to make effective VLPs against many diseases for a long time,” said Sumi Biswas, associate professor at the Jenner Institute at Oxford University. “We view this superglue technology as a game changer to enable faster development of effective vaccines against major global diseases. We are excited to begin the journey of taking this versatile and innovative approach forward and moving our new vaccines from the laboratory to human clinical testing.”

GV has a long history of investments in life sciences, with around half of its European investments involving health-tech companies.

“SpyBiotech has established a novel approach using platform VLP vaccine technology that shows promise in a number of addressable markets,” noted GV partner Tom Hulme. “We’re looking forward to working with a team of world-class scientists with extensive experience in vaccine development — spanning from vaccine design through to Phase II clinical trials — to develop more effective vaccines for a wide range of global diseases.”

GV isn’t the only Alphabet offshoot investing in life sciences. Back in January, Alphabet’s health-focused technology arm Verily Life Sciences (“Verily”) announced that it had received an $ 800 million investment from Singapore-based investment firm Temasek. Verily is setting out to build technology to “better understand health” and to prevent and manage diseases.

Alphabet actually has another health-focused subsidiary, called Calico, which was founded in 2013 by Google and Arthur D. Levinson as a biotech research entity with a focus on extending human life.

Elsewhere, Mark Zuckerberg and his wife Priscilla Chan, through The Chan Zuckerberg Initiative, recently announced a new $ 3 billion program designed to cure, prevent, or manage “all diseases” within their children’s lifetime.

Sign up for Funding Daily: Get the latest news in your inbox every weekday.

Let’s block ads! (Why?)

Big Data – VentureBeat

Read More
  • Recent Posts

    • NOT WHAT THEY MEANT BY “BUILDING ON THE BACKS OF….”
    • Why Healthcare Needs New Data and Analytics Solutions Before the Next Pandemic
    • Siemens and IBM extend alliance to IoT for manufacturing
    • Kevin Hart Joins John Hamburg For New Netflix Comedy Film Titled ‘Me Time’
    • Who is Monitoring your Microsoft Dynamics 365 Apps?
  • Categories

  • Archives

    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • June 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • July 2016
    • June 2016
    • May 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015
    • August 2015
    • July 2015
    • June 2015
    • May 2015
    • April 2015
    • March 2015
    • February 2015
    • January 2015
    • December 2014
    • November 2014
© 2021 Business Intelligence Info
Power BI Training | G Com Solutions Limited